Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2014
11/20/2014US20140343111 Diarylthiohydantoin compounds
11/18/2014US8889906 Tetralin and indane derivatives and uses thereof
11/18/2014US8889881 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/13/2014US20140336194 Method of treating contrast-induced nephropathy
11/11/2014US8883837 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/11/2014US8883836 Solid forms of bendamustine hydrochloride
11/11/2014US8883782 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
11/06/2014US20140329858 Cyclic Urea Derivatives As Androgen Receptor Antagonists
11/04/2014US8877940 Antibiotic tolerance inhibitors
11/04/2014US8877908 Stimulus-responsive apta chelamers
10/2014
10/30/2014US20140323520 Compositions and Methods for Increasing Proliferation of Adult Salivary Stem Cells
10/30/2014US20140323519 Heterocyclic compounds as b-raf inhibitors for treatment of cancer
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871746 Antiviral drugs for treatment of arenavirus infection
10/23/2014US20140315960 Prodrugs of non-steroid anti-inflammatory agents (nsaids)
10/23/2014US20140315957 Androgen receptor antagonists and uses thereof
10/23/2014US20140315945 Substituted Benzene Compounds
10/21/2014US8865912 Benzimidazole derivatives as PI3 kinase inhibitors
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865756 Inhibitors of HCV NS5A
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8864848 Zwitterionic azo dyestuffs for coloring keratin-including fibres
10/16/2014US20140309261 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
10/14/2014US8859780 Benzimidazole derivatives as selective blockers of persistent sodium current
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859590 Inhibitors of BACE1 and methods for treating Alzheimer's disease
10/14/2014US8859160 Monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell
10/14/2014US8859111 Materials for organic electroluminescent devices
10/14/2014US8858831 Scintillator compositions
10/09/2014US20140302010 Substituted benzimidazoles
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/07/2014US8853427 Neprilysin inhibitors
10/07/2014US8853403 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/07/2014US8853204 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein
10/02/2014WO2014160405A1 Compounds, compositions comprising same, and methods related thereto
10/02/2014WO2014159248A1 Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
10/02/2014WO2014157651A1 Amino acid amide compound and amino acid production method, and imidazolidine compound
09/2014
09/30/2014US8846952 Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846946 Germinal alkoxy/alkylspirocyclic substituted tetramate derivatives
09/25/2014US20140288302 Acetic acid amide derivative having inhibitory activity on endothelial lipase
09/25/2014US20140288119 Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
09/23/2014CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
09/18/2014WO2014140929A1 Process for drying bendamustine hydrochloride monohydrate
09/18/2014WO2014140878A1 Process for preparing alkyl esters of 4-(5-(bis(2-hydroxyethyl) amino)-1-methyl-1h-benzo[d]imidazol-2-yl)butyric acid
09/18/2014US20140275567 Process for preparing alkyl esters of 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1h-benzo[d]imidazol-2-yl)butyric acid
09/18/2014US20140275566 Process for drying bendamustine hydrochloride monohydrate
09/18/2014US20140275224 Cytosine deaminase modulators for enhancement of dna transfection
09/17/2014EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
09/16/2014US8835647 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
09/11/2014US20140256685 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
09/11/2014US20140256684 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
09/10/2014EP2773378A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids)
09/04/2014WO2013134085A8 Inhibitors of beta-secretase
09/04/2014US20140249196 N-benzylbenzimidazole modulators of pparg
09/04/2014US20140249148 Selective hdac3 inhibitors
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2772481A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof
09/02/2014US8822467 Biaryl oxyacetic acid compounds
09/02/2014US8822043 Organic compound and organic light-emitting device
09/02/2014CA2651128C Benzimidazole modulators of vr1
08/2014
08/28/2014WO2014128465A1 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase
08/28/2014US20140243334 Substituted hydoxamic acids and uses thereof
08/28/2014US20140243331 Inhibitors of inv(16) leukemia
08/28/2014US20140243324 Use of hematopoietic growth factor mimetics
08/28/2014US20140243310 Bicyclic compound
08/28/2014US20140243308 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/28/2014US20140237735 Zwitterionic azo dyestuffs for colouring keratin-including fibres
08/26/2014US8815926 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
08/26/2014US8815918 Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives
08/26/2014US8815592 Methods and compositions related to dopaminergic neuronal cells
08/26/2014CA2653039C Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
08/21/2014WO2014125970A1 Novel fused polycyclic compound and organic light emitting element including the same
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/20/2014EP2766344A1 Ep1 receptor ligands
08/19/2014US8809549 Esters of bendamustine and related compounds, and medical use thereof
08/19/2014US8809541 Heterocyclic compound, and composition for treating inflammatory diseases using same
08/19/2014US8809427 Phthalocyanine compound and production method therefor, and coloring composition containing the phthalocyanine compound
08/19/2014CA2612265C 2-substituted benzimidazoles
08/14/2014WO2014123239A1 Organic light-emitting device and display apparatus
08/14/2014US20140228380 Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease
08/14/2014US20140228378 N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
08/14/2014US20140228355 Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease
08/13/2014CN103980205A N-3-磺酰乙胺取代-5-环丙烷螺环乙内酰脲衍生物及其制备方法和应用 N-3- sulfonamide amine-substituted-5 cyclopropane spiro hydantoin derivatives, preparation method and application
08/13/2014CN103980204A 离子液体催化胺类与α，β－不饱和缺电子受体方法 Amines catalyzed by ionic liquid with α, β- unsaturated electron-deficient acceptor method
08/13/2014CN103980151A 作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物 Novel compounds as opioid receptor antagonists or inverse agonists of substance
08/13/2014CN103145622B 检测氰根离子的受体化合物及其合成和应用 Detection receptor compounds and their synthesis and application of cyanide ions
08/13/2014CN102746236B 一种制备功能化氧化石墨烯的方法 A feature of the method of preparation of graphene oxide
08/13/2014CN102503895B 苯并咪唑取代的丙烯腈衍生物的制备方法 Preparation of benzimidazole-substituted acrylonitrile derivative
08/12/2014US8802865 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
08/12/2014CA2621310C Sulfonamide derivative having pgd2 receptor antagonistic activity
08/07/2014WO2014121062A1 Selective hdac3 inhibitors
08/07/2014US20140221667 Factor viia inhibitor
08/07/2014US20140221658 Inhibition of cell proliferation
08/07/2014US20140221443 Novel hydrogen sulfate salt
08/07/2014US20140221431 Novel histone deacetylase inhibitor of benzamides and use thereof
08/07/2014US20140221339 Heterocyclic Derivative and Pharmaceutical Drug
1 2 3 4 5 6 7 8 9 10 11 12 ... 154